Showing 99 of 446 results

World Health Organization (WHO)
This background document has been prepared by the SAGE working group on smallpox and monkeypox vaccines to inform the discussions of SAGE at its 3-7 October 2022 meeting.
World Health Organization (WHO)
Annexes to the Vaccines and immunization for monkeypox interim guidance
Organización Mundial de la Salud
Estas recomendaciones provisionales1 se refieren a la vacuna mRNA-1273, fabricada por Moderna, que también se conoce como vacuna anti-COVID-19 de Moderna. En algunos países la vacuna se...
World Health Organization (WHO)
This Good Practice Statement summarizes current evidence on these variant-containing mRNA vaccines and provides guidance on their use in the context of the continued availability of ancestral...
Organisation Mondiale de la Santé (OMS)
Le présent document remplace la précédente note de synthèse sur les vaccins anti-hépatite A, publiée par l’OMS en 2012. Il contient des recommandations sur l’utilisation hors indications de...
World Health Organization (WHO)
This document replaces the 2012 WHO position paper on hepatitis A vaccines. It contains off-label recommendations.
Organización Mundial de la Salud
Recomendaciones provisionales para el uso de la vacuna de Valneva (‎VLA2001)‎ contra la COVID-19: orientaciones provisionales, versión inicial: 18 de agosto de 2022
Organisation Mondiale de la Santé (OMS)
Recommandations provisoires concernant l’utilisation du vaccin de Valneva (‎VLA2001)‎ contre la COVID-19 : orientations provisoires, première publication : 18 août 2022
Organización Mundial de la Salud
Recomendaciones provisionales sobre el uso de la vacuna BNT162b2 de Pfizer y BioNTech contra la COVID-19 en el marco de la Lista OMS de uso en emergencias: orientaciones provisionales, primera...
World Bank
The vaccine tracker was developed by World Bank in an effort to identify countries in urgent need of financial and operational support for vaccine deployment readiness, and to monitor, track and...
JSI
This is a link to a set of posts on vaccine introduction, supply chain and storage planning, and communication with communities,This is a link to a set of posts on vaccine introduction, supply chain...
Centers for Disease Control and Prevention (CDC)
This is a link to a post on how to generate demand for Covid-19 vaccination,This is a link to a post on how to generate demand for Covid-19 vaccination
Rockefeller Foundation
This is Rockefeller microsite on Covid-19 vaccine particularly focusing on increasing demand and accelerating global equity,This is Rockefeller microsite on Covid-19 vaccine particularly focusing on...
MoH Senegal, World Health Organization (WHO)
Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention,Analyse de la réponse du...
RDC Red cross
Analyse de la situation de vaccination contre la COVID-19 en RDC et stratégies de couverture des personnes les plus vulnérables,Analyse de la situation de vaccination contre la COVID-19 en RDC et...
UNICEF, World Health Organization (WHO)
Revue sur l'expérience du Rwanda en matière de mise à l’échelle de méthodes de suivi en temps réel et d’utilisation de solutions numériques pour renforcer la surveillance de la COVID-19,...
UNICEF, World Health Assembly
Highlighting Rwanda’s Experience Scaling Real-time Monitoring Approaches Using Digital Solutions to Support COVID-19 Surveillance, COVID-19 Vaccination and Case Management,Highlighting Rwanda’s...
World Health Organization (WHO)
Leasons learned on vaccination against COVID-19,Leasons learned on vaccination against COVID-19
Ministry of Health and Family Welfare, Government of India
India: Description de la plateforme électronique de vaccination contre la COVID-19 pour l’enregistrement et la déclaration ,India: Description de la plateforme électronique de vaccination...
World Health Organization (WHO)
Bhutan: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,Bhutan: Analysis of country COVID-19 response, identifying best...
World Health Organization (WHO)
The Gambia: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,The Gambia: Analysis of country COVID-19 response, identifying best...
Organisation Mondiale de la Santé (OMS), UNICEF
RDC: Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention,RDC: Analyse de la...
Banque Mondiale, Organisation Mondiale de la Santé (OMS)
Guinée Bissau: Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention pratiques...
World Health Organization (WHO)
Somalia: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,Somalia: Analysis of country COVID-19 response, identifying best...
World Health Organization (WHO)
Uganda: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,Uganda: Analysis of country COVID-19 response, identifying best...
World Bank, World Health Organization (WHO)
Guinea Bissau: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,Guinea Bissau: Analysis of country COVID-19 response,...
MoH South Sudan
South Sudan: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,South Sudan: Analysis of country COVID-19 response, identifying...
World Health Organization (WHO)
DRC: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,DRC: Analysis of country COVID-19 response, identifying best practices and...
World Health Organization (WHO)
Niger: Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention,Niger: Analyse de...
World Health Organization (WHO)
Mozambique: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,Mozambique: Analysis of country COVID-19 response, identifying best...
World Health Organization (WHO)
Botswana: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,Botswana: Analysis of country COVID-19 response, identifying best...
World Health Organization (WHO)
Syria: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans,Syria: Analysis of country COVID-19 response, identifying best practices...
Organización Panamericana de la Salud (OPS), World Health Organization (WHO)
Bolivia: Análisis de la respuesta de los países a la COVID-19, identificando las mejores prácticas y las brechas cruciales a tener en cuenta en los planes de respuesta futuros,Bolivia: Análisis...
World Health Organization (WHO)
This good practice statement has been developed based on the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 11 August 2022.
World Health Organization (WHO)
These are the annexes to the Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19.
World Health Organization (WHO)
This background document was prepared by the Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on COVID-19 vaccines to inform the discussions of SAGE for Valneva vaccine...
World Health Organization (WHO)
This interim recommendation pertains to the COVID-19 Valneva vaccine (VLA2001), developed by Valneva’s research and development teams in France and Austria with the marketing authorization holder,...
This document explains why gender considerations matter for immunization programming with examples of common gender-related barriers, along with concrete gender-responsive approaches and actions that...
This guide breaks down the development of situation analysis into four well detailed sections. 1. Collection and gathering of data 2. Complete immunization coverage and equity...
This guide is designed to help anyone in the health and immunization system identify and address barriers or leverage drivers to immunization by locally codesigning and evaluating human-centred,...
This position paper discusses the development of the BeSD for vaccine tool. It covers the 4 phases and key activities for the development of the tool. They include: • Initial development of the...
The guide includes tools and guidance for understanding behavioural and social drivers of vaccination, as well as guidance on how to gather, analyse and use the resuting data. Furthermore, this...
The website provides the latest data availble at the WHO. It includes a wide range of data types and different presentations. Some of the featured data sets include: global health estimates,...
Nationally representative household survey that provides data for wide range of monitoring and impact evaluation indicators in the areas of population, health and nutrition. ,Nationally...
This document includes information on efficacy; WHO prequalification status; safety; mixed schedules and interchangeability of products.,This document includes information on efficacy; WHO...
This document is includes information on WHO position on pneumococcal vaccines in infants in children; vaccine characteristics; safety; PCV performance; programmatic considerations; cost and...
The SYSVAC project aims to support National Immunization Technical Advisory Groups (NITAGs) and the World Health Organization Strategic Advisory Group of Experts on Immunization (WHO SAGE) in the...
This slide deck includes information on various potential criteria to assess rotavirus vaccines. Those include availability for WHO prequalified rotavirus vaccines supported by Gavi; efficacy, safety...
WHO’s Immunization, Vaccines and Biologicals department has developed these sheets within its priority area supporting the introduction of vaccines in Members States. They are primarily designed...
Allows access to up-to-date and comprehensive information on Gavi-supported vaccines. Provides an overview of WHO prequalified products for the vaccine groups that Gavi supports. The easy access to...
Provides an overview of the most recent and historical data on GAVI supported vaccine products that UNCIEF procures on behalf of countries. Provides information on vaccine, form, presentation, number...
Health accounts are a way for countries to monitor health spending across multiple streams, regardless of the entity or institution that financed and managed that spending. They allow health...
This simulation model can serve as a 'virtual laboratory' for decision-makers helping to answer what will be the impact of introducing new technologies (vaccines), what may be the effects of altering...
The survey has 4 broad groups of questions: what is the availability of different health services in a country, specifically what proportions of the different facility types offer specific health...
•The OneHealth Tool attempts to link strategic objectives and targets of disease control and prevention programmes to the required investments in health system. The tool provides planners with a...
The list is not an exhaustive list of vaccines used to immunize humans. It reflects those vaccines which, following a selection based on immunization priorities set by relevant UN agencies and WHO,...
World Health Organization (WHO)
This interim guidance for vaccination to help stop the monkeypox outbreak is provided to support the global response to an evolving situation. For information on different vaccines that may be...
World Health Organization (WHO)
Annexes to the recommendations for use of the CanSinoBIO Ad5-nCoV-S [‎recombinant]‎ vaccine (‎Convidecia™)‎ against COVID-19: grading of evidence: evidence to recommendation tables, first...
World Health Organization (WHO)
Interim recommendations for use of the CanSinoBIO Ad5-nCoV-S [‎recombinant]‎ vaccine (‎Convidecia™)‎ against COVID-19: interim guidance, first issued 19 May 2022
World Health Organization (WHO)
Background document to the WHO interim recommendations for use of the CanSinoBIO Ad5-nCoV-S vaccine (‎ConvideciaTM)‎ against COVID-19, issued 19 May 2022
UNIVAC is a single universal vaccine impact and cost-effectiveness decision support model with a standardized, accessible Excel-based (now based in R), interface and a familiar set of input steps and...
The Consortium aims to deliver a more sustainable, efficent, and transparent approach to generating disease burden and vaccine impact estimates. It works on aggregating the estimates across a...
Allows to browse data along actual datasets. Provides information on the global burden of diseases (globally, regionally, by country and by region). Provides country datasets for the burden of...
Organisation Mondiale de la Santé (OMS)
Les questions et réponses présentées ici se basent sur les recommandations provisoires les plus récentes du Groupe stratégique consultatif d’experts sur la vaccination (SAGE) de l’OMS...
Organisation Mondiale de la Santé (OMS)
Les présentes orientations provisoires ont été élaborées sur la base de l’avis émis par le Groupe stratégique consultatif d’experts (SAGE) sur la vaccination lors de sa réunion...
Organisation Mondiale de la Santé (OMS)
Les présentes orientations provisoires ont été élaborées sur la base de l’avis émis par le Groupe stratégique consultatif d’experts (SAGE) sur la vaccination lors de sa réunion...
Organisation Mondiale de la Santé (OMS)
Les présentes orientations provisoires ont été élaborées sur la base de l’avis émis par le Groupe stratégique consultatif d’experts (SAGE) sur la vaccination lors de sa réunion...
Organisation Mondiale de la Santé (OMS)
Organisation mondiale de la Santé. (‎2022)‎. Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 inactivé, CoronaVac, développé par Sinovac : orientations provisoires,...
Umit Kartoglu
This TechNet-21 webinar on vaccine vial monitor (VVM)-based vaccine management was given on the occasion of the publishing of “The Book of VVM: Yesterday-today-and-tomorrow” by Umit Kartoglu....
Mateusz Hasso-Agopsowicz
¿Cómo, dónde y cuándo vamos a utilizar parches de microarrays para administrar las vacunas contra el sarampión y la rubéola?
Kirstin Krudwig, Wendy Prosser
Dado que COVID exige tamaños de sesión más pequeños, es más importante que nunca considerar un tamaño de vial de vacuna más pequeño para adaptarse mejor a los tamaños de las sesiones.Esta...
Mateusz Hasso-Agopsowicz
Les vaccins contre la rougeole et la rubéole sont sûrs et efficaces, mais la couverture équitable, en particulier pour la deuxième dose de vaccin contenant la rougeole (MCV2), est bien...
Kirstin Krudwig, Wendy Prosser
Le COVID exigeant des sessions de plus petite taille, il est plus important que jamais de réduire la taille des flacons de vaccins pour mieux les adapter à la taille des sessions. Cette...
Mateusz Hasso-Agopsowicz
Measles and rubella vaccines are safe and effective, however, achieving equitable coverage, particularly for the second dose of measles containing vaccine (MCV2) is well below the 95% target of...
Kirstin Krudwig, Wendy Prosser
With COVID demanding smaller session sizes, it is more important than ever to consider smaller vaccine vial size to better tailor to session sizes.This presentation will share results from an...
PATH Living Labs, Oyugi Allela, Steve Osumba, Brenda Magula, Casildah Lumamba, Josephine Simwinga
PATH’s Living Labs Initiative used human-centered design methods to gather feedback on proposed labels for COVID-19 vaccine vials and cartons. Healthcare workers in Kenya and Zambia interacted with...
Organisation Mondiale de la Santé (OMS)
Les présentes recommandations provisoires portent sur le vaccin mRNA-1273 fabriqué par Moderna. Ce vaccin est aussi parfois appelé « vaccin anti-COVID-19 de Moderna ». Dans certains pays, le...
Organisation Mondiale de la Santé (OMS)
Le présent document remplace la note de synthèse de 2016 de l’OMS relative au premier vaccin homologué contre la dengue, le CYD-TDV. En novembre 2017, les résultats d’une analyse...
Organisation Mondiale de la Santé (OMS)
Cette note de synthèse actualisée sur les vaccins contre l’encéphalite japonaise (EJ) remplace la note de 2006 résumant la position de l’OMS sur le même sujet; elle renferme...
Immunization Academy
Grâce aux PCV (pastille de contrôle de vaccin), les agents de santé disposent d'un moyen rapide et facile de déterminer si un vaccin a été exposé à une chaleur excessive et probablement...
Organisation Mondiale de la Santé (OMS)
La présente note d’orientation révise et remplace la Déclaration de politique générale de l’OMS : utilisation deflacons de vaccin multidoses entamés lors de séances ultérieures de...
Organisation Mondiale de la Santé (OMS)
Conformément à son mandat, qui prévoit qu’elle conseille les États Membres en matière de politique sanitaire, l’OMS publie une série de notes de synthèse régulièrement mises à jour sur...
World Health Organization (WHO)
In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against...
Immunization Academy
Dans cette vidéo, nous examinerons la politique de l'OMS sur les flacons multidoses et la façon dont elle influe sur les décisions relatives à la conservation et à l'utilisation des flacons...
Organisation Mondiale de la Santé (OMS)
Comment lire les pastilles de contrôle des vaccins.
Single-Dose HPV Vaccine Evaluation Consortium
Le Consortium d’évaluation des vaccins à dose unique contre le PVH a été formé pour rassembler et synthétiser les données existantes et pour évaluer celles plus récentes sur le potentiel...
Single-Dose HPV Vaccine Evaluation Consortium
Ce document résume une revue et une évaluation complètes des données actuelles publiées sur le schéma de vaccination anti-PVH à dose unique, effectuées par les chercheurs du Consortium...
Organisation Mondiale de la Santé (OMS)
Vaccin ChAdOx1-S [recombinant] contre la COVID-19
Organisation Mondiale de la Santé (OMS)
Le CoronaVac  est un vaccin inactiv  contre la COVID-19 (cellule Vero) qui lutte contre la maladie   coronavirus 2019 (COVID-19) et stimule le syst me immunitaire de l’organisme sans...
Organisation Mondiale de la Santé (OMS)
Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 Pfizer-BioNTech, BNT162b2, en vertu du protocole OMS d’autorisation d’utilisation d’urgence : orientations provisoires,...
World Health Organization (WHO)
Background document to the WHO Interim recommendations for use of the Novavax (‎NVX-CoV2373)‎ vaccine against COVID-19